Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
Sponsored By: Evan Worrell (Republican)
First Reading
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Evan Worrell
Republican • House
Cosponsors
Michael Hite
Republican • House
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
On 1st reading, House Calendar
2/2/2026HousePlaced on House Calendar
1/30/2026HouseOn 1st reading, Special Calendar
1/29/2026HousePostponed on 1st reading, Special Calendar, until January 30, 2026
1/29/2026HouseBy substitute, do pass
1/28/2026HouseMarkup Discussion
1/22/2026HouseFiled for introduction
1/21/2026HouseTo Health and Human Resources
1/21/2026HouseIntroduced in House
1/21/2026HouseTo House Health and Human Resources
1/21/2026House
Bill Text
Committee Substitute
Introduced Version
Related Bills
HB 5692 — Supplemental appropriation, State Road Fund
HB 5691 — Supplemental appropriation, Department of Health
HB 5684 — Relating to authorizing the Supreme Court of Appeals to create child protection commissioners
HB 5686 — Relating to the timing of payments of annually required deposit into an eligible recipient’s Hope Scholarship account
HB 5685 — Relating to authorizing bonds for improvements to the West Virginia Science and Culture Center
SB 1064 — Redefining "long-term substitute" as it relates to public school personnel